Adient heads into earnings with shorts building and options heavily skewed to puts

Adient reports fiscal Q4 results on November 6 with short interest climbing, options positioned at nearly the most defensive level of the past year, and analysts having spent the past two months cutting targets into what is already a deeply discounted stock.

The clearest tension in the positioning data is in options. Puts outnumber calls by more than two to one, with the put/call ratio at 2.26, close to its 52-week high of 2.34, reached just last week. The 20-day average is 2.19, so the current reading is modestly above trend rather than a sharp spike, but the sustained elevation tells its own story: options traders have maintained heavy downside protection through October and into early November. This is not a sudden pre-earnings hedge. It has been the dominant posture for weeks.

Short interest has been building steadily and is not trivial at this level. Bears hold roughly 9.2% of the free float, up about 2.7% over the past week and 5.3% over the past month. The October acceleration is visible in the history: short shares sat around 6.5 million for most of the month before jumping to over 7 million in the final week. The FINRA fortnightly figure put settlement-date short interest at 7.1 million shares with days-to-cover of 7.4, confirming the commitment. The borrow market, however, offers no squeeze dynamic here. Availability is extremely loose at 1,571%, meaning lenders have roughly fifteen available shares for every share already borrowed. Cost to borrow has nudged up 14% over the week to 0.51%, but that remains a negligible carry cost. The short score has drifted higher over two weeks, reaching 54.6, but the lending market conditions make a forced cover scenario unlikely going into the print.

The Street broadly agrees the stock is cheap but has spent months walking targets lower, which is a different kind of signal. Five analysts cut price targets between mid-September and mid-October. Stifel trimmed to $21 on October 19 while keeping a Buy. Barclays cut to $22. UBS lowered to $23, also retaining Buy. The mean target from the analyst consensus is around $27.60, implying roughly 63% upside from the current $16.92. That gap is as much a warning as a promise: the spread between where analysts say the stock should trade and where it does trade has widened precisely because targets keep falling alongside the share price. The valuation multiples reflect the discount. EV/EBITDA is running at 3.4x and the P/E at 4.6x, both compressing over the past 30 days. The earnings yield factor ranks in the 92nd percentile, and the EV/EBIT factor in the 73rd, confirming the cheapness signal. The 90-day forward EPS momentum factor also ranks in the 97th percentile, suggesting estimate revisions have recently turned constructive even as near-term delivery remains uncertain. The bear case centres on loss-making metals contracts, uncompetitive plants in EMEA, and a European production environment that continues to disappoint. The bull case rests on market share gains through onshoring and a management projection of 5.0% to 5.5% margins over the next two to three years.

Insider activity in the 90-day window has been net negative. The most recent open-market transaction was a director sale of roughly $151,000 worth of shares in early September. Prior to that, the company's EVP, CLO, CHRO sold around $500,000 in June. These are modest in absolute terms but there have been no open-market purchases from senior executives in the visible period. The compensation-related awards in March and May are stock grants, not conviction buys. BlackRock holds 17.4% of shares outstanding, the dominant institutional position, adding modestly in the latest reported quarter. Dimensional and Pzena both held steady. Vanguard's Schedule 13G/A filed in March showed them exiting their position, a notable reduction from a prior 5.1% stake, though as with all 13D/G disclosures, positions are as-last-disclosed around the 5% threshold and movements below that level may not be reported.

The last comparable earnings event, the August 5 Q3 print, produced a 10.9% single-day decline and an 11-day move of negative 12%. The November 6 report will show how much of that damage has already been priced into a stock trading at multi-year lows, and whether management's margin recovery narrative can survive contact with another quarter of EMEA production headwinds.